참고문헌
- Annemans L, Remy V, Lamure E, et al (2008). Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium. J Med Econ, 11, 135-50. https://doi.org/10.3111/13696990801961611
- Chaturvedi AK (2010). Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health, 46, S20-6.
- Dillner J, Kjaer SK, Wheeler CM, et al (2010). Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ, 341, c3493. https://doi.org/10.1136/bmj.c3493
- Ebrahim SH, McKenna MT, Marks JS (2005). Sexual behaviour: related adverse health burden in the United States. Sex Transm Infect, 81, 38-40. https://doi.org/10.1136/sti.2003.008300
- Insinga RP (2006). Annual productivity costs due to cervical cancer mortality in the United States. Womens Health Issues, 16, 236-42. https://doi.org/10.1016/j.whi.2006.06.005
- Insinga RP, Dasbach EJ, Elbasha EH (2005). Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics, 23, 1107-22. https://doi.org/10.2165/00019053-200523110-00004
- Koutsky LA, Harper DM (2006). Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine, 24, S3/114-21.
- Kulasingam SL, Hughes JP, Kiviat NB, et al (2002). Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA, 288, 1749-57. https://doi.org/10.1001/jama.288.14.1749
- Lipsy RJ (2008). Assessing the short-term and long-term burden of illness in cervical cancer. Am J Manag Care, 14, S177-84.
- Max W, Rice DP, Sung HY, et al (2003). The economic burden of gynecologic cancers in California, 1998. Gynecol Oncol, 88, 96-103. https://doi.org/10.1016/S0090-8258(02)00101-4
- Ministry of Health, Singapore (2009). Communicable diseases surveillance in Singapore 2008.
- National Health Insurance Research Database (2009). Disease Burden of Genital Wart in Taiwan.
- National Skin Center (2006). Sexually Transmitted Infections Notification Report.
- Paavonen J, Naud P, Salmeron J, et al (2009). Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet, 374, 301-14. https://doi.org/10.1016/S0140-6736(09)61248-4
- Parkin DM, Bray F (2006). Chapter 2: The burden of HPVrelated cancers. Vaccine, S3, 11-25.
- Singapore Cancer Registry (2004). Trends in cancer incidence in Singapore 1968-2002 (Singapore,), pp. xi, 181 , 181 map 129 cm. + 181 CD-ROM (184 183/184 in.)
- Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
- Wiley D, Masongsong E (2006). Human papillomavirus: the burden of infection. Obstet Gynecol Surv 61, S3-14. https://doi.org/10.1097/01.ogx.0000221010.82943.8c
- Wong WK (2008). Population Trends 2008 (Singapore Department of Statistics).
피인용 문헌
- Assessment of psychosocial impact of genital warts among patients in Singapore vol.11, pp.4, 2014, https://doi.org/10.1071/SH13189
- Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012 vol.10, pp.12, 2015, https://doi.org/10.1371/journal.pone.0146185
- Understanding the Low Level of Cervical Cancer Screening in Masaka Uganda Using the ASE Model: A Community-Based Survey vol.10, pp.6, 2015, https://doi.org/10.1371/journal.pone.0128498
- The global impact of non-communicable diseases on healthcare spending and national income: a systematic review vol.30, pp.4, 2015, https://doi.org/10.1007/s10654-014-9984-2
- Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland vol.12, pp.5, 2017, https://doi.org/10.1371/journal.pone.0177762
- Estimating the burden of genital warts in Taiwan vol.14, pp.6, 2017, https://doi.org/10.1071/SH17013
- The Direct Medical Costs of Diseases Associated with Human Papillomavirus Infection in Manitoba, Canada vol.16, pp.2, 2018, https://doi.org/10.1007/s40258-017-0367-1
- Clinical and economic impact of school-based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis vol.125, pp.4, 2018, https://doi.org/10.1111/1471-0528.15106